HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
C Rabascio Selected Research
C Rabascio Research Topics
Disease
2
Multiple Myeloma
10/2020 - 01/2009
2
Waldenstrom Macroglobulinemia (Macroglobulinemia)
02/2011 - 04/2010
2
Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2007 - 08/2000
2
Neoplasms (Cancer)
08/2000 - 05/2000
1
Febrile Neutropenia
10/2020
1
Infections
02/2011
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2010
1
Disease Progression
08/2000
1
Leukemia
05/2000
1
Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
05/2000
1
Lymphoma (Lymphomas)
05/2000
Drug/Important Bio-Agent (IBA)
3
Rituximab (Mabthera)
FDA Link
02/2011 - 02/2007
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
10/2020 - 08/2000
2
Cladribine
FDA Link
Generic
02/2011 - 04/2010
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
10/2020
1
plerixafor
FDA Link
10/2020
1
Nucleotides
IBA
04/2010
1
Deoxycytidine
IBA
04/2010
1
deoxyguanosine kinase
IBA
04/2010
1
Ribonucleotide Reductases (Ribonucleotide Reductase)
IBA
04/2010
1
Messenger RNA (mRNA)
IBA
04/2010
1
5'-Nucleotidase (5' Nucleotidase)
IBA
04/2010
1
Nucleoside Transport Proteins (Nucleoside Transporter)
IBA
04/2010
1
Chlorambucil (Leukeran)
FDA Link
02/2007
1
Sultan
IBA
08/2000
1
Tea
IBA
08/2000
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
05/2000
Therapy/Procedure
2
Therapeutics
02/2011 - 02/2007
2
Drug Therapy (Chemotherapy)
04/2010 - 08/2000
1
Autologous Transplantation
01/2009